theory clinical_14_4
imports Main

begin

typedecl entity
typedecl event

consts
  BRCA2 :: "entity ⇒ bool"
  RAD51 :: "entity ⇒ bool"
  Humans :: "entity ⇒ bool"
  Involved :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  RecombinationRepair :: "event ⇒ bool"
  Homologous :: "entity ⇒ bool"  (* Changed from event to entity *)
  In :: "event ⇒ entity ⇒ bool"
  Molecules :: "entity ⇒ bool"
  Binding :: "event ⇒ bool"
  Joining :: "event ⇒ bool"
  Undamaged :: "entity ⇒ bool"
  Catalyze :: "event ⇒ bool"
  Promote :: "event ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Interaction :: "event ⇒ bool"
  Through :: "event ⇒ event ⇒ bool"
  Repair :: "entity ⇒ bool"
  Essential :: "event ⇒ bool"
  For :: "event ⇒ event ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"

(* Explanation 1: BRCA2 and RAD51 homolog 1 are both involved in homologous recombination repair in humans. *)
axiomatization where
  explanation_1: "∀x y z e. BRCA2 x ∧ RAD51 y ∧ Humans z ∧ Involved e ∧ Agent e x ∧ Agent e y ∧ RecombinationRepair e ∧ Homologous x ∧ Homologous y ∧ In e z"

(* Explanation 2: The binding of BRCA2 and RAD51 homolog 1 catalyzes the joining of undamaged homologous molecules. *)
axiomatization where
  explanation_2: "∃x y z e1 e2. BRCA2 x ∧ RAD51 y ∧ Molecules z ∧ Binding e1 ∧ Joining e2 ∧ Undamaged z ∧ Homologous z ∧ Catalyze e1 ∧ Agent e1 x ∧ Agent e1 y ∧ Patient e2 z"

(* Explanation 3: BRCA2, through its interaction with RAD51 homolog 1, promotes the joining of undamaged homologous repair molecules in humans, and this interaction is essential for the promotion process. *)
axiomatization where
  explanation_3: "∃x y z w e1 e2 e3. BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans w ∧ Joining e1 ∧ Undamaged y ∧ Homologous y ∧ Repair y ∧ Promote e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Interaction e2 ∧ Through e1 e2 ∧ Agent e2 x ∧ Agent e2 z ∧ In e1 w ∧ Essential e3 ∧ For e3 e1"

theorem hypothesis:
  assumes asm: "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1"
  (* Hypothesis: BRCA2 promotes the joining of undamaged homologous repair molecules via RAD51 homolog 1 in humans. *)
  shows "∃x y z e1 e2. BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1 ∧ Joining e2 ∧ Undamaged y ∧ Homologous y ∧ Repair y ∧ Promote e2 ∧ Agent e2 x ∧ Patient e2 y ∧ Via e2 z ∧ In e2 e1"
proof -
  (* From the known information, we have BRCA2 x, Molecules y, RAD51 z, and Humans e1. *)
  from asm have "BRCA2 x ∧ Molecules y ∧ RAD51 z ∧ Humans e1" by blast
  (* Explanation 3 provides a direct implication that BRCA2 promotes the joining of undamaged homologous repair molecules in humans. *)
  (* We can use the logical relation Implies(C, E) to infer that the binding of BRCA2 and RAD51 homolog 1 leads to the promotion of joining. *)
  from explanation_3 obtain e2 where "Joining e2 ∧ Undamaged y ∧ Homologous y ∧ Repair y ∧ Promote e2 ∧ Agent e2 x ∧ Patient e2 y ∧ Via e2 z ∧ In e2 e1" sledgehammer
  then show ?thesis <ATP>
qed

end
